Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 10.3% | 10.3% | 11.9pp | 10 of 40 | 4 |
| EPSEPS | 14.6% | 10.6% | 38.3pp | 13 of 40 | 9 |
| Op cash flowOperating cash flow | 7.1% | 25.3% | 82.5pp | 19 of 36 | 15 |
| EBITDAEBITDA | 10.6% | 12% | 13.7pp | 10 of 40 | 4 |
| FCFFree cash flow | 6.2% | 25.3% | 99.1pp | 19 of 36 | 15 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: CPAY on the compounders surface · All compounders, ranked